Archive

Diabetes drug shows promise in protecting kidneys

Written by Charlie King | 22 Nov 2024

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An… read more.

The role of digital technology in diabetes prevention and management

Written by Charlie King | 17 Nov 2024

Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People’s Hospital in China, have been leading a special collection and published an editorial in Frontiers… read more.

ENDO 2024 press conferences to highlight male birth control, anti-obesity medications

Written by Charlie King | 23 May 2024

Researchers will delve into emerging research in diabetes, obesity, reproductive health and other aspects of hormone health during the Endocrine Society’s ENDO 2024 news conferences June 1-4. The… read more.

Weekly insulin injections have the potential to be as effective in diabetes management as now-common daily injection regimes

Written by Charlie King | 2 Nov 2023

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according… read more.

Increase in gestational diabetes rates linked largely to screening

Written by Charlie King | 21 Mar 2023

Gestational diabetes has been reported to be on the rise, but a new study from British Columbia found that changes in screening practices explain much of the increase…. read more.

Fasting can lead to remission of Type 2 diabetes

Written by Bruce Sylvester | 21 Jan 2023

Persons with Type 2 diabetes have achieved complete remission of disease following use of an intermittent fasting diet intervention, researchers reported on Dec. 22, 2022 in the Journal… read more.

Intermittent fasting may reverse type 2 diabetes, according to study

Written by Charlie King | 18 Dec 2022

After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after… read more.

Findings support repurposing rheumatoid arthritis drug auranofin for diabetes

Written by Charlie King | 20 Oct 2022

Researchers at Baylor College of Medicine and collaborating institutions discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms. The study, which was… read more.

BCG vaccine appears to protect patients with type 1 diabetes from COVID-19 infection

Written by Bruce Sylvester | 23 Aug 2022

Multiple does of the Bacillus Calmette-Guerin (BCG) vaccine appears to offer patients with type 1 diabetes strong protection against COVID-19, researchers reported on August 15, 2022 in Cell… read more.

Not enough men in their 40s are getting screened for diabetes, study finds

Written by Charlie King | 19 Jul 2022

Not enough men in Alberta, Canada — especially those in their 40s — are getting tested for diabetes, putting them at risk for heart disease, cancer and other… read more.

Endocrine Society urges Congress to pass bill to make insulin more affordable for people with diabetes

Written by Charlie King | 27 Jun 2022

The Endocrine Society announces its endorsement of the bipartisan insulin bill introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME) that would take steps to reduce out-of-pocket… read more.

Obesity-related fertility issues may be improved by correcting blood sugar levels

Written by Charlie King | 6 Jun 2022

Reproductive hormone levels in females with obesity may be partially restored by lowering blood glucose levels, leading to improved fertility, according to a study published in the Journal of… read more.

1 2 3 … 5 Next »

Archive

Subscribe for our mailing list

Follow Us